In virtually all cancers studied, including hepatocellular carcinoma, gastric and colon cancers, glioma, skin cancer, lung cancer, renal cancer, prostate cancer (PC), and breast cancer, FABP5 expression is associated with increased tumor growth, migration, and/or invasiveness. The gene discussed is FABP5; the disease is hepatocellular carcinoma.